CL vs IMA · P/E 34, rev $20.38B vs rev $9.2M
Colgate-Palmolive Company (CL) versus ImageneBio, Inc. (IMA) — a side-by-side from cached financials, not a winner call.
Colgate-Palmolive Company (CL) is a household & personal products company listed on US.
ImageneBio, Inc. (IMA) is a biotechnology company listed on NASDAQ.
Latest reported CL revenue for 2025-12-31 was $20.38B. Net income was $2.13B. Revenue was up 1.4% from 2024-12-31 to 2025-12-31. CL currently screens at market cap $70.88B and trailing P/E 34.3.
Latest reported IMA revenue for 2023-12-31 was $9.2M. Net income was -$68.2M. Revenue was down 41.3% from 2022-12-31 to 2023-12-31. IMA currently screens at market cap $64.7M.
CL currently screens at market cap $70.88B and trailing P/E 34.3. IMA currently screens at market cap $64.7M.
Not investment advice. Open the CL and IMA stock pages for the full models.
Not investment advice.